Trial NCT03052725

View at ClinicalTrials.gov 
Org. Study IDs: C38072-AS-30066
Secondary IDs: 2016-004661-23

Last trial update was posted on 2022-12-14

MeSH Interventions

Reslizumab

MeSH Conditions

Asthma Pulmonary Eosinophilia

Other Conditions

Eosinophils, Asthma

Stopping Reasons

Parent Studies didn't meet their primary endpoint so study was terminated.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID